Immunotherapy of Gynaecological High-Risk Human
Papilloma Virus Infection With Human
Leukocyte Ultrafiltrate

H. Spitzbart; U. B. Hoyme

doi:10.1155/S1064744900000156

Infectious Diseases in Obstetrics and Gynecology (Jan 2000)

Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate

H. Spitzbart,
U. B. Hoyme

Affiliations

H. Spitzbart: Department of Obstetrics and Gynecology, Frauenklinik Erfurt Gorkistrasse 6, Erfurt D-99084, Germany
U. B. Hoyme: Department of Obstetrics and Gynecology, Frauenklinik Erfurt Gorkistrasse 6, Erfurt D-99084, Germany

DOI: https://doi.org/10.1155/S1064744900000156
Journal volume & issue: Vol. 8, no. 3-4
pp. 120 – 123

Abstract

Read online

Objective: In this preliminary presentation the outcome of women following systemic treatment of cervical human papilloma virus (HPV) with a leukocyte ultrafiltrate is reported.

Published in Infectious Diseases in Obstetrics and Gynecology

ISSN: 1064-7449 (Print); 1098-0997 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://www.hindawi.com/journals/idog/

About the journal